FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer

The transcription factor Forkhead‐box A1 (Foxa1), a member of the FOX class of transcription factors, has been implicated in the pathogenesis of lung, esophageal and prostate cancers. We have recently identified transcriptional activation of p27 by FOXA1. In this study, we analyzed the activities and expression pattern of FOXA1 in breast cancer. Forced expression of FOXA1 inhibited clonal growth of breast cancer cell lines, and FOXA1 levels inversely correlated with growth stimuli. In the estrogen receptor (ER)‐positive MCF‐7 cells, FOXA1 increased p27 promoter activity and inhibited the ER pathway activity. Analysis of FOXA1 expression in breast tissue arrays revealed significantly higher expression in pure ductal carcinomas in situ compared to invasive ductal carcinomas (IDC); and in IDC, high expression of FOXA1 was associated with favorable prognostic factors. Yet, FOXA1 expression was noted in a subset of the ER‐negative tumors. Taken together, our findings suggest a growth inhibitory role for FOXA1, and identify it as a novel, potential prognostic factor in breast cancer. © 2006 Wiley‐Liss, Inc.

[1]  W. Gerald,et al.  An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen , 2006, Oncogene.

[2]  J. Mirosevich,et al.  Foxa1 and Foxa2 Interact with the Androgen Receptor to Regulate Prostate and Epididymal Genes Differentially , 2005, Annals of the New York Academy of Sciences.

[3]  M. Erdos,et al.  BRCA1 inhibition of estrogen receptor signaling in transfected cells. , 1999, Science.

[4]  Barry Komm,et al.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. , 2003, Endocrinology.

[5]  C. Osborne,et al.  Forkhead Homologue in Rhabdomyosarcoma Functions as a Bifunctional Nuclear Receptor-interacting Protein with Both Coactivator and Corepressor Functions* , 2001, The Journal of Biological Chemistry.

[6]  M. Pagano,et al.  The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer , 2000, Breast Cancer Research.

[7]  Y. Doki,et al.  Deregulated expression of p27(Kip1) in human breast cancers. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  R. Costa,et al.  Analysis of hepatocyte nuclear factor-3 beta protein domains required for transcriptional activation and nuclear targeting. , 1995, Nucleic acids research.

[9]  Zhiyuan Hu,et al.  Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Yasunori Miyamoto,et al.  Cell-type dependency of two Foxa/HNF3 sites in the regulation of vitronectin promoter activity. , 2002, Biochimica et biophysica acta.

[11]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[12]  T. Unterman,et al.  Hepatocyte nuclear factor-3 (HNF-3) binds to the insulin response sequence in the IGF binding protein-1 (IGFBP-1) promoter and enhances promoter function. , 1994, Biochemical and biophysical research communications.

[13]  M. Weiss,et al.  Phenotypic effects of the forced expression of HNF4 and HNF1alpha are conditioned by properties of the recipient cell. , 1998, Journal of cell science.

[14]  Qifeng Yang,et al.  Retinoid, Retinoic Acid Receptor β and Breast Cancer , 2002, Breast Cancer Research and Treatment.

[15]  K. Kaestner,et al.  The Hepatocyte Nuclear Factor 3 (HNF3 or FOXA) Family in Metabolism , 2000, Trends in Endocrinology & Metabolism.

[16]  M. Stoffel,et al.  Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Shousha,et al.  High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Yoshihide Hayashizaki,et al.  A comprehensive search for HNF-3alpha-regulated genes in mouse hepatoma cells by 60K cDNA microarray and chromatin immunoprecipitation/PCR analysis. , 2003, Biochemical and biophysical research communications.

[20]  M. Lacroix,et al.  Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update , 2004, Breast Cancer Research and Treatment.

[21]  Keith Baggerly,et al.  Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression , 2004, Breast Cancer Research.

[22]  Renjie Jin,et al.  The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. , 2003, Molecular endocrinology.

[23]  Clifford A. Meyer,et al.  Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1 , 2005, Cell.

[24]  Frank R. Lin,et al.  Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. , 2002, Molecular cell.

[25]  David E. Misek,et al.  The Hepatocyte Nuclear Factor 3 α Gene, HNF3α (FOXA1), on Chromosome Band 14q13 Is Amplified and Overexpressed in Esophageal and Lung Adenocarcinomas , 2002 .

[26]  P. Carlsson,et al.  Forkhead transcription factors: key players in development and metabolism. , 2002, Developmental biology.

[27]  A. Jacob,et al.  The HNF-3α Transcription Factor Is a Primary Target for Retinoic Acid Action , 1999 .

[28]  S. Burley,et al.  Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5 , 1993, Nature.

[29]  Jonathan P. Katz,et al.  Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo. , 1999, Genes & development.

[30]  Céline Lefebvre,et al.  From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Céline Lefebvre,et al.  Location analysis of estrogen receptor target promoters reveals that FOXA 1 defines a domain of the estrogen response , 2005 .

[32]  G Leclercq,et al.  About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-α gene (ESR1) in breast cancer , 2004, Molecular and Cellular Endocrinology.

[33]  D. Tong,et al.  Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines , 2002, Breast Cancer Research and Treatment.

[34]  R. Weigel,et al.  Ligand-dependent Interaction of Estrogen Receptor-α with Members of the Forkhead Transcription Factor Family* , 2001, The Journal of Biological Chemistry.

[35]  E. Lai,et al.  Hepatocyte nuclear factor 3 beta contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head protein , 1992, Molecular and cellular biology.

[36]  H. Rochefort,et al.  How to target estrogen receptor-negative breast cancer? , 2003, Endocrine-related cancer.

[37]  E. Ogata,et al.  Critical role for p27Kip1 in cell cycle arrest after androgen depletion in mouse mammary carcinoma cells (SC-3) , 1998, Oncogene.

[38]  E. Williamson,et al.  BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27Kip1 , 2006, Oncogene.

[39]  外丸 靖浩.  A Comprehensive search for HNF-3α-regulated genes in mouse hepatoma cells by 60K cDNA microarray and chromatin immunoprecipitation/PCR analysis , 2004 .